POGK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.161600E-01
Normal-vs-Stage2
8.786400E-01
Normal-vs-Stage3
1.071980E-01
Normal-vs-Stage4
2.142800E-01
Stage1-vs-Stage2
9.425400E-01
Stage1-vs-Stage3
1.294040E-01
Stage1-vs-Stage4
1.317000E-01
Stage2-vs-Stage3
7.155600E-02
Stage2-vs-Stage4
2.314800E-01
Stage3-vs-Stage4
6.136000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.876800E-01
Normal-vs-AfricanAmerican
1.879230E-01
Normal-vs-Asian
5.946000E-01
Caucasian-vs-AfricanAmerican
1.315800E-01
Caucasian-vs-Asian
2.136600E-01
AfricanAmerican-vs-Asian
6.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.449800E-01
Normal-vs-Female
9.955000E-01
Male-vs-Female
4.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.520600E-01
Normal-vs-Age(41-60Yrs)
7.240200E-01
Normal-vs-Age(61-80Yrs)
9.716400E-01
Normal-vs-Age(81-100Yrs)
6.261400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.740400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.103600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.541400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.622200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.738210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.363800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.474400E-01
Normal-vs-Daily Drinker
5.905600E-01
Normal-vs-Weekly Drinker
8.355400E-01
Normal-vs-Occasional Drinker
4.047600E-01
Normal-vs-Social Drinker
7.996000E-01
Non Drinker-vs-Daily Drinker
4.079200E-01
Non Drinker-vs-Weekly Drinker
5.062400E-01
Non Drinker-vs-Occasional Drinker
6.225900E-02
Non Drinker-vs-Social Drinker
4.031600E-01
Daily Drinker-vs-Weekly Drinker
2.208200E-01
Daily Drinker-vs-Occasional Drinker
1.856110E-02
Daily Drinker-vs-Social Drinker
1.616780E-01
Weekly Drinker-vs-Occasional Drinker
6.228600E-01
Weekly Drinker-vs-Social Drinker
9.345600E-01
Occasional Drinker-vs-Social Drinker
4.071200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.097700E-02
Normal-vs-Grade 2
1.442890E-03
Normal-vs-Grade 3
1.443830E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.241700E-02
Grade 1-vs-Grade 3
3.787800E-02
Grade 1-vs-Grade 4
2.097700E-02
Grade 2-vs-Grade 3
4.755200E-01
Grade 2-vs-Grade 4
1.442890E-03
Grade 3-vs-Grade 4
1.443830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.225000E-01
Normal-vs-NonDiabetic
8.638000E-01
Diabetic-vs-NonDiabetic
2.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.465800E-01
Normal-vs-NoPancreatitis
9.522600E-01
Pancreatitis-vs-NoPancreatitis
9.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.387000E-01
Normal-vs-N1
9.127200E-01
N0-vs-N1
6.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.970400E-01
Normal-vs-TP53-NonMutant
8.319200E-01
TP53-Mutant-vs-TP53-NonMutant
3.423700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
